CCC Intelligent Solutions 株価情報 (NASDAQ: CCCS)

最新ニュース CCC Intelligent Solutions (NASDAQ:CCCS) 株価情報

CCC INTELLIGENT SOLUTIONS HO

CCC Intelligent Solutions

CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, and AI-enabled digital workflows. It operates in a single segment being Domestic segment which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in United States and China. Majority of the revenue is generated from United States.

CCC Intelligent Solutions Holdings Inc. - Common Stock

CCC Intelligent Solutions Holdings Inc

Analysts' ratings for Solventum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOLV#NYSE">SOLV</a>) over the last quarter vary from bullish to bearish, as provided by 9 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Solventum, presenting an average target of $80.22, a high estimate of $87.00, and a low estimate of $71.00. Observing a 6.8% increase, the current average has risen from the previous average price target of $75.11. 
<img src="https://www.benzinga.com/files/images/story/2025/1747677672_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A comprehensive examination of how financial experts perceive Solventum is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jason Bednar</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$87.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Jason Bednar</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$78.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Jason Bednar</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Patrick Wood</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$80.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Steven Valiquette</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$82.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>David Roman</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$71.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Vik Chopra</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$75.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Jason Bednar</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$84.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Travis Steed</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$85.00</td>
<td>$80.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Solventum. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Solventum compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Solventum's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Solventum's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/SOLV/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Solventum analyst ratings.</a>
<h2>Get to Know Solventum Better</h2>
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.
<h3>Solventum: Financial Performance Dissected</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Solventum displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 2.68%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Solventum's net margin excels beyond industry benchmarks, reaching 6.62%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Solventum's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.4% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Solventum's ROA stands out, surpassing industry averages. With an impressive ROA of 0.95%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a high debt-to-equity ratio of 2.43, Solventum faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

SOLV

Assessing Solventum: Insights From 9 Financial Analysts

In the current market session, Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) share price is at $114.75, after a 2.07% decrease. Over the past month, the stock spiked by 33.02%, but over the past year, it actually fell by 30.31%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2025/1747677670_0.png" alt="Past Year Chart" />

<h3>A Look at Advanced Micro Devices P/E Relative to Its Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 151.9 in the Semiconductors &amp; Semiconductor Equipment industry, Advanced Micro Devices Inc. has a lower P/E ratio of 85.53. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1747677670_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

News

Intraday Update

Markets

Price Over Earnings Overview: Advanced Micro Devices

Coupang's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPNG#NYSE">CPNG</a>) short percent of float has fallen 5.65% since its last report. The company recently reported that it has 12.59 million shares sold short, which is 1.17% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.55 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Coupang Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747677671_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Coupang has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Coupang's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Coupang's peer group average for short interest as a percentage of float is 10.77%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

CPNG

What Does the Market Think About Coupang?

Analysts' ratings for Barings BDC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBDC#NYSE">BBDC</a>) over the last quarter vary from bullish to bearish, as provided by 4 analysts.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $9.25, a high estimate of $10.00, and a low estimate of $8.50. This current average has decreased by 8.6% from the previous average price target of $10.12. 
<img src="https://www.benzinga.com/files/images/story/2025/1747677665_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The analysis of recent analyst actions sheds light on the perception of Barings BDC by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Derek Hewett</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$10.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Finian O'Shea</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$8.50</td>
<td>$9.00</td>
</tr>
<tr>
<td>Finian O'Shea</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$9.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Ryan Lynch</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$9.50</td>
<td>$10.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Barings BDC. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Barings BDC compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Barings BDC's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Barings BDC's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/BBDC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Barings BDC analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Discovering Barings BDC: A Closer Look</h2>
Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. Barings employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.
<h3>Barings BDC: Financial Performance Dissected</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Decline in Revenue: Over the 3M period, Barings BDC faced challenges, resulting in a decline of approximately -26.12% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Barings BDC's net margin is impressive, surpassing industry averages. With a net margin of 93.96%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Barings BDC's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.74%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Barings BDC's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.19%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Barings BDC's debt-to-equity ratio is below the industry average. With a ratio of 1.27, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBDC

4 Analysts Assess Barings BDC: What You Need To Know

B of A Securities analyst Derek Hewett maintains Barings BDC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBDC#NYSE">BBDC</a>) with a Buy and lowers the price target from $11 to $10.

Price Target

B of A Securities Maintains Buy on Barings BDC, Lowers Price Target to $10

AST SpaceMobile Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) shares are trading lower Monday, adding to losses since the company reported first-quarter earnings last week that included revenue and earnings below expectations despite strong <a href="https://www.benzinga.com/general/space/25/05/45361586/ast-spacemobile-reports-q1-earnings-key-highlights-from-the-quarter">operational updates</a>.
What To Know: Last week, AST SpaceMobile reported $718,000 in revenue for the first quarter, missing analyst estimates by over $3 million. The company also posted a net loss of 20 cents per share, missing estimates for a loss of 18 cents per share, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
The sell-off on Monday appears to be technical after shares were rejected around the $27.50 level multiple times following earnings. 
Despite being unable to gain upward momentum, AST SpaceMobile highlighted several achievements during the quarter, including "strong" progress on regulatory approvals and a multi-provider satellite orbital launch plan with five contracted launches over the next six to nine months.  
The company also said it advanced its SpaceMobile network commercialization efforts and has an expected revenue opportunity of $50 million to $75 million in the second half of 2025.
Executives <a href="https://www.benzinga.com/general/space/25/05/45368803/ast-spacemobile-sets-75-million-target-for-2025-as-cfo-andrew-johnson-says-revenue-is-ramping-on-plan-amid-surging-demand-for-direct-to-device-satellite-connectivity">highlighted</a> continued progress on building a satellite broadband network that connects directly to unmodified smartphones, noting that the company has signed deals with 45 mobile operators globally.
AST SpaceMobile also pointed to significant U.S. government contracts in progress, including a $43 million deal with the U.S. Space Development Agency and a new $20 million agreement through the Defense Innovation Unit.
Following the print, Scotiabank analyst Andres Coello lowered the price target from $47.90 to $45.40. The company has a Street-high target of $63 and a Street-low target of $15, according to Benzinga<a href="https://www.benzinga.com/quote/ASTS/analyst-ratings"> analyst data</a>.
AST SpaceMobile also has a strong momentum score of 98.18, given its sharp rise of more than 365% over the past year, according to <a href="http://pro.benzinga.com">Benzinga Pro</a> data. 
Price Action: AST SpaceMobile shares were down 7.73% at $24.59 at the time of publication Monday, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45497403/is-the-dollars-global-reserve-role-at-risk-after-moodys-downgrade">Is The Dollar&#8217;s Global Reserve Role At Risk After Moody&#8217;s Downgrade? </a></li>
</ul>
Image Via Shutterstock.

Movers

ASTS

AST SpaceMobile Shares Are Facing Selling Pressure Today: What's Going On?

B of A Securities analyst Tazeen Ahmad maintains Sutro Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRO#NASDAQ">STRO</a>) with a Underperform and lowers the price target from $1 to $0.8.

STRO

B of A Securities Maintains Underperform on Sutro Biopharma, Lowers Price Target to $0.8

JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) CEO Jamie Dimon, known for <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44294343/jamie-dimons-crypto-change-of-heart-trump-once-claimed-shift-but-jpmorgan-ceo-still-a-skeptic-when-it-comes-to-bitcoin">his repeated criticisms</a> of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), acknowledged at the bank's investor day this week that the firm will now allow clients to buy the cryptocurrency, though it will not offer custody services.
What Happened: Dimon's remarks mark a shift in tone for the leader of the largest U.S. bank, <a href="https://www.theblock.co/post/354883/jamie-dimon-says-jpmorgan-will-allow-clients-to-buy-bitcoin-but-firm-will-not-custody-it?utm_source=twitter&amp;utm_medium=social">according</a> to The Block.
Despite referring to Bitcoin as a "<a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42940832/jamie-dimon-says-hes-not-against-blockchains-but-trades-guns-on-bitcoin-again-it-has-no-intrinsic-value-i-just-dont-feel-great-about">Ponzi scheme</a>" as recently as January and maintaining he sees "no value" in it, the firm is adapting to rising institutional and retail demand for digital assets.
The CEO also remained skeptical about blockchain's long-term impact. 
"We've been talking about blockchain for 12 years, not much has happened, it ain't like AI," he said at a separate event in September 2024.
Although Dimon continues to distance himself from Bitcoin philosophically, his bank has become increasingly engaged with the broader blockchain sector. 
Last year, he acknowledged JPMorgan as <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44033154/jamie-dimon-was-a-believer-in-smart-contract-cryptos-long-before-jpmorgan-started-piling-on-ethereum-etfs-heres-what-he-said">a significant user</a> of blockchain technology, highlighting the firm&#8217;s involvement in various enterprise initiatives.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45498737/altcoin-rotation-is-coming-expert-says-will-eth-xrp-dogecoin-benefit">Altcoin Rotation Is Coming, Expert Says: Will ETH, XRP, Dogecoin Benefit?</a>
Why It Matters: The firm's evolving stance comes amid a broader policy shift in Washington.
The Trump administration has taken a more favorable view of digital assets, prompting more engagement from traditional financial institutions. 
Earlier this year, Federal Reserve Chair Jerome Powell said U.S. banks can serve crypto clients, provided they adequately manage the associated risks.
Still, regulatory concerns remain. 
In January, TD Cowen noted that banks are likely to maintain limited exposure to crypto due to ongoing worries around money laundering compliance and risk management frameworks.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45496435/strategy-adds-765-million-in-bitcoin-faces-lawsuit-over-btc-holdings">Strategy Adds $765 Million In Bitcoin, Faces Lawsuit Over BTC Holdings</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Jamie Dimon Opens JPMorgan To Bitcoin Access Despite Longstanding Criticism

B of A Securities analyst Tazeen Ahmad maintains Denali Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNLI#NASDAQ">DNLI</a>) with a Buy and lowers the price target from $28 to $27.

DNLI

B of A Securities Maintains Buy on Denali Therapeutics, Lowers Price Target to $27

B of A Securities analyst Sara Senatore maintains Cava Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) with a Buy and raises the price target from $112 to $121.

CAVA

B of A Securities Maintains Buy on Cava Group, Raises Price Target to $121

Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) continues to head lower Monday. This follows Friday's loss of more than 4.5% after <a href="https://www.benzinga.com/top-stories/25/05/45381191/first-solar-eyes-best-2-day-rally-since-2013-after-gop-tax-plan-spares-key-clean-energy-credits">recent gains</a>. There is a good chance the move lower will continue.
A recent move higher was probably due to a short squeeze. Stocks can drop significantly when a short squeeze ends. This is why our trading team has made Sunrun our Stock of the Day.
People who sell short anticipate a decline in the price of a stock.
They borrow shares from someone else and sell them. They hope that after the stock declines, they will buy the shares back and return them. Their profit will be the price they sold short for minus the price they bought the shares back at.
If a stock rises above the price the short seller sold the shares for, they start to lose money. And if the price keeps rising, their losses grow. Sometimes, some of the short sellers start to panic as the stock continues to rally.
They enter the market as buyers and this forces the price even higher.
Read Also: <a href="https://www.benzinga.com/government/25/05/45499183/how-tariff-uncertainty-is-driving-a-us-talent-exodus">How Tariff Uncertainty Is Driving A US Talent Exodus</a>
If the price gets high enough, some of the people who loaned their shares to the short sellers will decide they want to sell them. This forces the short seller to buy the shares back regardless of the price, so they can return them.
At this point, the stock can go parabolic. As you can see on the chart, this is what happened with Sunrun last week.
When a short squeeze ends and the panic is over, the stock typically makes a rapid and large move lower. They can even drop back to the levels they were trading at when the squeeze started.
It isn't a coincidence that Sunrun reversed off the $13.35 level. This level had been support and prices that were support can turn into resistance.
Some who bought shares in October saw an opportunity to finally exit their positions at breakeven when the stock returned to this price last week. The large amounts of sell orders placed by these remorseful buyers created resistance at the price that was support.
As this short squeeze unwinds, there is a good chance the stock continues to head lower.
Read Next: • <a href="https://www.benzinga.com/25/05/45492889/americas-credit-strength-just-got-cut-again-should-you-panic">America&#8217;s Credit Strength Just Got Cut Again: Should You Panic?</a>
Photo: Shutterstock

Technicals

Options

Stock Of The Day: Is The Sunrun Short Squeeze Over?

WIIM

AutoZone shares are trading higher after Wells Fargo raised its price target from $3,850 to $4,200 while maintaining an Overweight rating.

ENPH

FSLR

Shares of solar stocks are trading lower amid political risk to clean-energy incentives following reports detailing GOP plans to cut clean-energy credits.

Piper Sandler analyst Jason Bednar upgrades Solventum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOLV#NYSE">SOLV</a>) from Neutral to Overweight and raises the price target from $78 to $87.

Upgrades

Piper Sandler Upgrades Solventum to Overweight, Raises Price Target to $87

<a href="https://www.youtube.com/watch?v=KeGLM7JPPYo">https://www.youtube.com/watch?v=KeGLM7JPPYo</a>

Politics

Economics

Federal Reserve

General

Fed's Kashkari Says Very Bullish There Will Be Lots Of Jobs In Future U.S. Economy

HC Wainwright &amp; Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ARMP#AMEX">ARMP</a>) with a Buy and raises the price target from $7 to $9.

ARMP

HC Wainwright & Co. Maintains Buy on Armata Pharmaceuticals, Raises Price Target to $9

One of the benefits&nbsp;<a href="https://substack.com/redirect/1b7f3cf6-9b8c-48b8-9e8c-657e8bb35809?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">of aging</a>&nbsp;as an investor is that you accumulate invaluable experience and perspective by living through a lot of very bad economic and financial market events.
These include events when, in the moment, it felt like things had permanently taken a turn for the worse. But time after time, you're reminded that you can't keep the U.S. economy and stock market down for very long.
I like to reflect on those events and recall the unpleasant memories because it helps me better process current and future periods of turmoil and crisis. And the more I reflect, the more I feel like I understand why we keep bouncing back.
<h2 class="wp-block-heading">From the Asian Financial Crisis to the COVID-19 Pandemic </h2>
In the late 1990s, I was just another immature high school kid without many cares in the world. I didn't really keep up with current events. But I remember the Asian Financial Crisis because it was one of the topics in prayers my dad would give at his church in Kentucky. I'll never forget hearing "IMF" come up in those Korean prayers because it was so unusual.
Among other things, the Korean won collapsed by more than half against the U.S. dollar over a very short period at the time. This was a particularly big problem for immigrants closely tied to family back in Korea. I didn't quite understand it at the time, but I remember the mood being disturbingly gloomy for a while.
<figure class="wp-block-image"><a href="https://substack.com/redirect/8c96a367-2e63-438d-a2f7-10c8651a8053?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://ci3.googleusercontent.com/meips/ADKq_NbINJfv5qQh_mHfNAY3Ren2hmfavqULpETqyrT62IAKgBp1GuHcKsWWczq82QUGEIHKukQLVGfPH60szFIs7o2ULNAs2hI74Ykf5yqRx7-ZiP7ih17uwpGn70blunqyGROIAeb-WAQbjArVL5At4St4X3wNc3cE9bHDcdNrbYLzgpxNuZiBX4vUCCXPynbm4By4skuDjxD91-tMivdp90eXPcrjLnj3cJIohK7mOdJejOWbZW1xdoXzAbbeUtDjWF9Q9G08Om8EcfTbZNI2486pcqWJo12NH9WosBIzTY-Wix9XXmZWh-3R=s0-d-e1-ft#https://substackcdn.com/image/fetch/w_1100,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa5a023c5-705e-4037-918a-edf40c616438_939x450.png" alt="" /></a><figcaption class="wp-element-caption">The Asian Financial Crisis saw major currencies quickly collapse. (Source:&nbsp;<a href="https://substack.com/redirect/48d241f2-f332-40a5-ad4c-7ebb39d30b2b?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">FRED</a>)</figcaption></figure>
I don't have many memories from the Dot-com Bubble bursting. Back then, I had little interest in or exposure to the stock market, and neither did the people around me. But I do remember watching 9/11 live on TV in my dorm with my roommates at Boston University. I remember not being able to get a hold of family members in New York and Kentucky because the phones were overloaded. I remember the extreme range of reactions from my friends: some fled Boston out of fear; some used it as an excuse to skip some classes; some explored joining the armed forces. Everyone was rattled. Everyone felt less safe.
And for my college friends and I, it soon became clear that we would all be entering a tighter job market with an elevated unemployment rate. Things weren't great.
<figure class="wp-block-image"><a href="https://substack.com/redirect/3012d5c1-016c-4c41-bd92-903bc05ed66d?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://ci3.googleusercontent.com/meips/ADKq_Nb0sOgwPLHdgVjD8GPkACVilOFgV79U6eM4TgYfAGwnctzGbMR6ckGKGaMPPJmsb335K_PFhJz4WzItHVGkc-bciz_-F14_LohPnz1e2HpiOm2QhOBOd-J9EIHnekR9fLA1aNgN6uRaT1X3WbGbRx5DOGupi9ZDHNneKuAvXZGEmDVM3ReFQZBcUyY2f1H-Ay1mbnYPx4VYbn3W5AJiz5f6hjLhCVp-ffWkATcoPZI6z76v5VgSvSyrABDdTIpl0jEQnJHTd9V9EnXbPaFFJYucwOVhTrusQsdzlUGKQhL8qv42U2AvlkHz=s0-d-e1-ft#https://substackcdn.com/image/fetch/w_1100,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F5a352b63-7540-4ce3-8c89-537c29545c92_939x465.png" alt="" /></a><figcaption class="wp-element-caption">The economy looked great when I entered college in 2000. It wasn't as great when I graduated in 2004. (Source:&nbsp;<a href="https://substack.com/redirect/489aeeec-4d13-46b3-9414-adcfd9c83d5a?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">FRED</a>)</figcaption></figure>
After graduating from college in 2004 and after months of searching, I randomly got a job as a contract paralegal where I got my first serious introduction to equity research. I quickly became hooked on learning about the what made the stock market move.&nbsp;<a href="https://substack.com/redirect/1b7f3cf6-9b8c-48b8-9e8c-657e8bb35809?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">In 2006</a>, I got a job at Forbes Newsletters researching and writing up stock picks. I also enrolled in the CFA program that year, which helped me develop a sophisticated understanding of things like mortgage backed securities, collateralized debt obligations, derivatives, and value-at-risk models.
This education super-charged my fear and my feeling of hopelessness as the world tipped into recession in 2007 and spiraled into Global Financial Crisis (GFC) in 2008. The more I understood, the more I felt like there was no way out of it. And many pundits seemed to agree. I remember respected financial market prognosticators going on TV and proclaiming that the government's bailouts of the big banks, the automakers, and the GSEs were proof that it was "the end of capitalism."
<figure class="wp-block-image"><a href="https://substack.com/redirect/066cd371-b8d8-4648-b40b-879d376f5e68?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://ci3.googleusercontent.com/meips/ADKq_NaHljZ6b-KoD6nT2WIv6xYdXPocFXWXu4HDJUY33P7BLHHUuuQ_fNcef2S4ee27E-mWgEAGeIAKHuTZutEw925FgEKQoJcsGaOFNx6uuhwUGHB80PHQmc79NaMeJi3P31c6CoqomzQ6O1nLY4H8AdfuHkSGpMw4-9ngz9pxbETBVMF83_jAQVwa8a-1W72rxOjozDed21eOENit9woECSpcIIkP4vX2JbKzhtQ4WKfAI00mG0nvj4CV2oSNoTAIDh-X74mBJC3__f0xwQ0KVRCGdfG7tHc03FeMW7gctrD4InpzQ2dt3rtJww=s0-d-e1-ft#https://substackcdn.com/image/fetch/w_1100,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0396d240-eb39-492f-925c-2a8f3825df94_1472x834.png" alt="" /></a><figcaption class="wp-element-caption">The S&amp;P 500 fell 57% from its Oct 2007 high of 1,565 to its March 2009 low of 666. (Source: Yahoo Finance)</figcaption></figure>
It wasn't the end of capitalism, though many were convinced the housing market would never come back as we entered a "<a href="https://substack.com/redirect/68d9f88d-7fd8-4862-8ff9-e7c83cc7921b?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">new normal</a>" of slow growth. Another popular phrase in the wake of the crisis was "<a href="https://substack.com/redirect/6cb20fca-d357-4cd6-b289-bee51a7d8229?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">secular stagnation</a>." Admittedly, I was sold on the idea that economic growth would forever be a long slog. You can't blame me. In 2010,&nbsp;<a href="https://substack.com/redirect/1b7f3cf6-9b8c-48b8-9e8c-657e8bb35809?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">I got laid off from my job</a>&nbsp;and I re-entered a job market flooded with unemployed people with backgrounds in finance.
But the post-GFC recovery helped me appreciate the resilience of the consumers and businesses propelling the economy forward. I got a great job in 2011, and over the next decade my income soared. Those years were riddled with numerous macro hiccups, but nothing could keep the economy and the stock market from accelerating again and blasting through record highs.
And then came the COVID-19 pandemic.
Those first 6-9 months were surreal. I remember feeling like I was living a sci-fi horror film. At many points I thought this new strange way of life would be permanent. Meanwhile, I was constantly worried that the whole economy would collapse on itself.
<figure class="wp-block-image"><a href="https://substack.com/redirect/0688f86e-f536-4b28-9774-f75e1a04a46d?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://ci3.googleusercontent.com/meips/ADKq_NbscFUtA6IwDvX5NqUG8Nn6t2luLEGjO3a3XB7MX6TCBprlzYQZAJM_uHvLxP7d4AJfLNYHRefSH_Er7I17FlRvRBHpeA6mhHqGCiHh3K-hpEduxkBNNBG19fTTnzyjVgV-XtvjCtlxH7qRsNMXrmtm-S6Zuoaoz4Fvk5k4rmmt_Bd_qMXqQHQFOT1DjsPAagFkDv1f1k3ZIbW_5cmkt03dS8AkuhXxL6DS6WThOZ9DJ-5nvGEcB9samE1oWNv7I3WHxqfxDhFqE79XUQJDokhNycPZtfhhztb7jEfa2lpps4m6iBhRokrN=s0-d-e1-ft#https://substackcdn.com/image/fetch/w_1100,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9c91b707-de5d-4221-ade3-af302a81b88a_939x465.png" alt="" /></a><figcaption class="wp-element-caption">COVID-19 caused the economy to nearly screech to a halt. (Source:&nbsp;<a href="https://substack.com/redirect/489aeeec-4d13-46b3-9414-adcfd9c83d5a?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">FRED</a>)</figcaption></figure>
The discovery of the vaccine certainly helped things turn around. Fast forward a few years, and most things in the economy are back to normal. Notably,&nbsp;<a href="https://substack.com/redirect/89de024a-89ed-401a-804f-8b1d28d3b361?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">cruise</a>&nbsp;and&nbsp;<a href="https://substack.com/redirect/fd044ff2-d85d-449e-898a-e92b554d80ba?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">air travel</a>&nbsp;have more than recovered as most people have gotten comfortable again with being in tight spaces with strangers —&nbsp;<a href="https://substack.com/redirect/ca970b27-04e4-4579-8604-6191fa0425a7?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">unless it's in an office for work</a>.
So despite the pain, the trauma, and even the loss of life, all these experiences eventually confirmed that we'll always bounce back.
<h2 class="wp-block-heading">People will always want things to be better &#x1f4c8;</h2>
The economy and the stock market have&nbsp;<a href="https://substack.com/redirect/0ac3db5d-094a-4e05-8ba2-568c104debf2?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">always had</a>&nbsp;an upward bias.
This makes sense&nbsp;<a href="https://substack.com/redirect/421fc3e1-659f-4eee-8449-f3ccc06c20d5?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">if you think about it</a>. There are way more people who want things to be better, not worse. And that demand incentivizes entrepreneurs and businesses to supply better goods and services. The winners in this process get bigger as revenue grows. Some even get big enough to get listed in the stock market. As revenue grows,&nbsp;<a href="https://substack.com/redirect/edda2a69-5be1-43a1-8786-99ad82579e8f?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">so do earnings</a>. And earnings drive stock prices.
I can't imagine anything changing these attitudes. Sure, there will be periods of when we feel angry and hopeless along the way. But we're never gonna wake up one day and decide we have everything we want or settle on the idea that what we've got can't be improved on.
And there will always be a sense of urgency. Even during difficult periods, people understand that life won't wait. You're getting older. You're kids are getting older. You're parents are getting older. If you have the resources,&nbsp;<a href="https://substack.com/redirect/cdba9ccf-e431-4691-add0-603ee3b2cd5f?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">you won't put your lives on hold</a>. This is bullish as it keeps the wheels on the economy spinning.
Sure, many things change after all the events I mentioned. But things are always changing. Importantly, the changes that stuck have never prevent the economy and the markets from setting new records.
<h2 class="wp-block-heading">Where we are today</h2>
If you've been following the news at all over the past two months, you've probably heard at least a few folks talking about how the Trump administration's approach to trade policy is damaging the U.S.'s standing in the world while also threatening to send the global economy into recession.
As the stock market tumbled, phrases like "<a href="https://substack.com/redirect/01ee3155-4eb4-40a5-8f63-26b5ac1895a4?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">sell America</a>" and "<a href="https://substack.com/redirect/c8b83f7d-203d-4e29-bae4-6879cb4e671c?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">end of American exceptionalism</a>" began to trend.&nbsp;<a href="https://substack.com/redirect/0e3bfd9a-aef4-447f-a3b3-5dc39ab36d0a?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">Popular measures of investor sentiment</a>&nbsp;tanked.
<figure class="wp-block-image"><a href="https://substack.com/redirect/6a7ef8a2-1216-4073-a921-adb64c11fe1e?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://ci3.googleusercontent.com/meips/ADKq_NaY2UYtD_m_cCbiQrz03XzG6_fndw5nNrVMqzc_hzDYFLqXa7gZhAx_yg__5Pb3HA0i1-i8n4JGx7uNsuDwwfxT1PgQODmLHJYt7d-3jt8UJnq96h3Yid8wZhZJXPSpM4TtVBZ0qeu5sC5A7oPRLxt1AVcDZ1HVYXga1EDrhXxpy3k1lZCp_CcPtbiHF5pf2K_XDPm1hIFUSmbTLNgXM2rnYNIgyiDZ7Tm8nPJqAEs3_7z8RcN8jelSZDuFy9K2l7TkYMQ_EsrdJOdjvD9EQbq-jSzcvL02-f2H9vqhfQ1e2S0sOXJ-Mqt-Dw=s0-d-e1-ft#https://substackcdn.com/image/fetch/w_1100,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F412304bb-608f-4ee0-b9a4-76f38a1a9f03_1972x842.png" alt="" /></a><figcaption class="wp-element-caption">Barron's Big Money poll revealed historic levels of bearishness. (Source:&nbsp;<a href="https://substack.com/redirect/52ba27cc-a783-4128-a30d-b6f0e285e87c?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">Barron's</a>)</figcaption></figure>
To be clear, I think the past two months created some damage, and we have yet to learn the extent of that damage. It's certainly possible that we're in a recession or headed for one. And it's certainly possible the stock market could take another leg lower.
But I'm nowhere near convinced that we're destined for a extended, multi-year period of turmoil and pain.
Our system is amazing at self-correcting. Whether it's through votes or something else, we always seem to find a way to get things back on track toward increasing prosperity and improving our standard of living.
And to repeat&nbsp;<a href="https://substack.com/redirect/29c413c7-c5cd-4845-b921-67ca23a9ede1?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">what I said last week</a>: There's basically three scenarios investors always have to consider: 1) Things improve from here, and the market goes up; 2) Things get worse before they get better, which means markets could fall before resuming a more firm rally; or 3) Things get worse and never get better.
If we're facing scenario 3, then we may have bigger problems than stocks not recovering. But scenario 3 has&nbsp;<a href="https://substack.com/redirect/84055449-e2e7-434a-9e0d-ab334afbeef6?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">never played out</a>.
Scenarios 1 and 2 favor long-term investors. Maybe things get worse before they get better. (Note:&nbsp;<a href="https://substack.com/redirect/f1a11344-054b-4ae9-b89d-52cc5dd2c420?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">Timing market</a>&nbsp;bottoms is&nbsp;<a href="https://substack.com/redirect/e0630f35-18e4-4bdd-a1db-86faac336c59?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">nearly impossible</a>.) But staying long the stock market covers you in case the low of this cycle is behind us.
I'll leave you with Warren Buffett said earlier this month at&nbsp;<a href="https://substack.com/redirect/19bde3b3-6107-4aae-b826-8c47b51bd5d2?j=eyJ1Ijoid252OGYifQ.jVQb6opeiKhMTzCAB2x0eMpa3LqEuHgwpXD1DeTk7x0" rel="noreferrer noopener" target="_blank">Berkshire Hathaway's annual meeting</a>:
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">"We're always in the process of change. We'll always find all kinds of things to criticize in the country. …&nbsp;If you don't think the United States has changed since I was born in 1930… We've gone through all kinds of things. We've gone through great recessions. We've gone through world wars. We've gone through the development of the atomic bomb that we never dreamt of when I was born. So I would not get discouraged about the fact that it doesn't look like we've solved every problem that's come along."
</blockquote>
The 94-year-old investor has lived through everything, and he's made a fortune investing in the stock market along the way.
&#8211;

Equities

Government

Long Ideas

Macro Notification

Market Summary

Psychology

Opinion

Personal Finance

Remembering Moments When I Thought Things Took A Permanent Turn For The Worse

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.institutionalpropertyadvisors.com%2F&amp;esheet=54257117&amp;newsitemid=20250519504201&amp;lan=en-US&amp;anchor=Institutional+Property+Advisors+%28IPA%29&amp;index=1&amp;md5=e2951cec00b67290040dd5c556531169">Institutional Property Advisors (IPA)</a>, a division of <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.marcusmillichap.com%2F&amp;esheet=54257117&amp;newsitemid=20250519504201&amp;lan=en-US&amp;anchor=Marcus+%26amp%3B+Millichap+%28NYSE%3AMMI%29&amp;index=2&amp;md5=368a3f4e5f5cb1c099725e50b0f4cf77">Marcus &amp; Millichap (NYSE:</a><a href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) dedicated to serving the company's institutional clients, announced today the sale of Zaterra, a 392-unit multifamily property in Chandler, Arizona. The asset traded for $137.5 million, or $350,765 per unit.

Marcus & Millichap's Institutional Property Advisors Announces Sale Of Zaterra For $137.5M

Piper Sandler analyst Charles Neivert upgrades Methanex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEOH#NASDAQ">MEOH</a>) from Neutral to Overweight and raises the price target from $36 to $48.

MEOH

Piper Sandler Upgrades Methanex to Overweight, Raises Price Target to $48

U.S. stocks trimmed early-session losses by midday Monday, as investors showed limited concern after Moody's downgraded U.S. sovereign credit from Aaa to Aa1, effectively stripping the world's largest economy of its last <a href="https://www.benzinga.com/25/05/45492889/americas-credit-strength-just-got-cut-again-should-you-panic">top-tier credit rating. </a>
The S&amp;P 500 index hovered near Friday's close. A green end to the session would mark the sixth consecutive daily gain. The Nasdaq 100 also traded flat, while the Dow Jones Industrial Average outperformed, and small caps lagged. 
Bond markets initially reacted sharply, with 30-year Treasury yields spiking above 5% following the downgrade. Yet, buying interest emerged during the session, pulling yields back to 4.95%. The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) still was down 0.6% on the day. 
The U.S. dollar index (DXY) weakened 0.6% to 100.40, reflecting moderate selling pressure on the greenback. Sector performance was muted overall, except for energy, which fell 1.5%. Crude oil slipped 0.4%, while natural gas dropped 6% amid oversupply concerns. 
Gold rose 1% to $3,235 per ounce, supported by safe-haven flows. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rallied 2%, climbing above the $105,000 mark.
<h3 class="wp-block-heading">Monday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,824.92</td>
<td>0.4%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,456.60</td>
<td>0.1 %</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,965.78</td>
<td>0.1 %</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,102.02</td>
<td>-0.5%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 1:05 p.m. ET</figcaption></figure>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45497403/is-the-dollars-global-reserve-role-at-risk-after-moodys-downgrade">Is The Dollar&#8217;s Global Reserve Role At Risk After Moody&#8217;s Downgrade?</a></li>
</ul>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) inched 0.1% up to $594.91.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.4% to $428.18.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;edged 0.1% higher to $522.01.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.5% to $208.80.</li>
<li>The&nbsp;Health Care&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>) outperformed, up 0.7%; the&nbsp;Energy&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 1.5%.</li>
</ul>
<h3 class="wp-block-heading">Monday&#8217;s Stock Movers</h3>
<ul class="wp-block-list">
<li>UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) jumped 8%, extending Friday's 6% surge, after several company executives bought shares <a href="https://www.benzinga.com/25/05/45493652/700m-asset-manager-exits-unitedhealth-stock-says-medicare-advantage-is-facing-a-perfect-storm">during the recent selloff</a>.</li>
<li>New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) rallied 21%, following a nearly 60% decline last week amid lower-than-expected earnings. </li>
<li>Novavax Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) surged 18% after the FDA approved its Nuvaxovid COVID-19 vaccine <a href="https://www.benzinga.com/government/regulations/25/05/45488265/novavax-wins-limited-fda-nod-for-covid-shot-cleared-only-for-seniors-high-risk-groups-amid-safety-scrutiny">for high-risk individuals</a>, including seniors over 65 and those aged 12–64 with underlying health conditions. Shares of Moderna Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) rose 6.4%.</li>
</ul>
Now Read: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45497403/is-the-dollars-global-reserve-role-at-risk-after-moodys-downgrade">Is The Dollar&#8217;s Global Reserve Role At Risk After Moody&#8217;s Downgrade?</a></li>
</ul>
Image: Shutterstock

Macro Economic Events

Sector ETFs

Bonds

Broad U.S. Equity ETFs

Treasuries

Econ #s

Tech

ETFs

SPDR Dow Jones Industrial Average ETF Trust

MRNA

NVAX

iShares Trust Barclays 20+ Year Treasury Bond Fund

Select Sector SPDR-Consumer Discretionary

Comments

CCC Intelligent Solutions

ニュース

最新ニュース CCC Intelligent Solutions (NASDAQ:CCCS) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル